MIMETAS and Galapagos to Develop Human Disease Models On-a-Chip
January 13, 2014
Leiden, the Netherlands - MIMETAS and Galapagos (Euronext: GLPG) have entered into a research collaboration on the development of organ-on-a-chip-based human disease models for new medicine development. The companies will collaborate to develop miniaturized 3D cell culture models that mimic specific aspects of human diseases. These models will be applied to the identification and improvement [...]
University of Sussex selects Dotmatics’ Studies Notebook to assist their Drug Discovery research
January 13, 2014
Bishops Stortford, UK.Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, is pleased to announce today that the Translational Drug Discovery Group at the University of Sussex has selected Dotmatics’ fully searchable and web-based Electronic Laboratory Notebook, Studies Notebook, to complement their existing Dotmatics data management platform. The [...]
Distek, Inc. Releases the LabEye Digital Video System
January 13, 2014
North Brunswick, NJ – Distek, Inc., an industry leader in pharmaceutical laboratory testing instruments, accessories and validation services, is excited to release the LabEye Digital Video System for Dissolution testing monitoring and recording. The LabEye Digital Video System, engineered by TwoSquare Science streamlines pharmaceutical testing in both R&D and Quality environments. Designed specifically for laboratory [...]
January 13, 2014
SAN DIEGO -- BioNano Genomics announced today the purchase of an Irys™ System by UC Davis to assist, among other projects, in completing the genome assembly of Aegilops tauschii, one of three progenitors of today's bread wheat. The team of researchers at UC Davis, led by Dr. Jan Dvorak, will use the Irys System in [...]
LabCorp to Offer New FDA approved Breast Cancer Prognostic Test
January 13, 2014
BURLINGTON, N.C. -- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the launch of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay, an FDA approved breast cancer prognostic gene signature assay developed by NanoString Technologies, Inc. Prosigna provides a risk category and a numerical score to assess the probability of breast cancer recurrence [...]
Bruker Corporation Announces the Appointment of Dr. Gilles Martin to its Board of Directors
January 13, 2014
BILLERICA, Mass. -- Bruker Corporation (NASDAQ:BRKR) announced the election of Dr. Gilles Martin to its Board of Directors, effective as of today. Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group, a Luxembourg-based international life-sciences company which provides a range of analytical testing services to clients across multiple industries. Dr. Martin [...]
Agilent Technologies Awards Grant for Translational Research in Cardiometabolic Disease
January 13, 2014
SANTA CLARA, Calif.-- Agilent Technologies Inc. (NYSE: A) today announced it has awarded a grant to the newly established Duke Molecular Physiology Institute. The DMPI research team is using Agilent's integrated biology solutions to gain new insights into the metabolic and physiologic aspects of major chronic diseases such as cardiovascular disease. DMPI is headed by [...]
January 13, 2014
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX) and University of Bristol, Bristol, UK, announced today that they have collaboratively designed a wheat genotyping array and analyzed data from experiments as part of an effort to understand wheat genetics and breeding with a goal of ensuring guaranteed sustainable production. Axiom® Wheat Genotyping Array (Axiom Wheat [...]
MedMira Embarks on Major U.S. Expansion with VWR International, LLC Agreement
January 13, 2014
Halifax, Nova Scotia – MedMira Inc., (MedMira) (TSXV: MIR), a developer of rapid testing technologies and solutions, today announced a U.S. distribution agreement with VWR International LLC, a global solutions provider of laboratory supplies and services with worldwide sales in excess of $4.1 billion in 2012. Through this new agreement, MedMira will benefit from the [...]
New Laboratory Test Helps Hospitals Detect Newly Emerging Strains of Drug-Resistant Superbug
January 13, 2014
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has received FDA clearance to market the BD MAX™ MRSA XT Assay for use on the fully-automated BD MAX™ System. This is the second assay from BD Diagnostics capable of detecting [...]
